BMY vs MUR · P/E 17, rev $24.46B vs P/E 60, rev $1.66B
Bristol-Myers Squibb Company (BMY) versus Murphy Oil Corporation (MUR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Murphy Oil Corporation (MUR) is a oil & gas e&p company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MUR revenue for 2026-06-30 was $1.66B. Net income was $285.2M. MUR currently screens at market cap $5.06B and trailing P/E 59.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MUR currently screens at market cap $5.06B and trailing P/E 59.8.
Not investment advice. Open the BMY and MUR stock pages for the full models.
Not investment advice.